Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 5, 2016, Pages 953-958

  González, Carlos A ^a   Sanz Anquela, José Miguel ^b   Companioni, Osmel ^a   Bonet, Catalina ^a   Berdasco, María ^c   López, Consuelo ^d   Mendoza, Jorge ^d   Martín Arranz, Ma Dolores ^e   Rey, Enrique ^f   Poves, Elvira ^g   Espinosa, Laura ^g   Barrio, Jesús ^h   Torres, Ma Ángeles ^h   Cuatrecasas, Miriam ⁱ   Elizalde, Ignasi ^j   Bujanda, Luis ^k,p   Garmendia, Maddi ^k,p   Ferrández, Ángel ^h   Muñoz, Guillermo ^l,p   Andreu, Victoria ^m   Paules, Ma Jose ⁿ   Lario, Sergio ^o,p   Ramírez, Ma Jose ^o,p   Gisbert, Javier P ^d   Ramas, Mercedes ^d   Casals Seoane, Fernando ^d   Madrigal, Beatriz ^h   Sánchez Ceballos, Francisco ^f   Borrego, Gloria ^g   Beceiro, Inmaculada ^g   Barenys, Merçé ^m   García Zafra, Beatriz ^m   Cosme, Angel ^q   Larzabal, Mikel ^q   Juan, Jose ^e   Kreilinger, Pozo ^e   Roncalés, Pilar ^l   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^h HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^k UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^l HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^m HOSPITAL DE VILADECANS   (Spain)

ⁿ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^o PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^p INSTITUTO DE SALUD CARLOS III   (Spain)

^q HOSPITAL DONOSTIA   (Spain)

more..

Author keywords

Follow up study; Gastric cancer risk; Intestinal metaplasia

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER CENTER; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHRONIC GASTRITIS; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX; SMOKING; SPAIN; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOID; STOMACH LESION; STOMACH LYMPHOMA; TUMOR BIOPSY; TUMOR DIFFERENTIATION; ADENOCARCINOMA; BIOPSY; CELL TRANSFORMATION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE COURSE; GASTRITIS, ATROPHIC; METAPLASIA; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STOMACH; STOMACH NEOPLASMS; TIME FACTOR;

ADENOCARCINOMA; ADULT; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HUMANS; LONGITUDINAL STUDIES; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPAIN; STOMACH; STOMACH NEOPLASMS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84964466942     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13249     Document Type: Article

References (20)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010 (Dec 15); 127 (12): 2893-917.
2. Sant M, Aareleid T, Berrino F et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann. Oncol. 2003; 14: v61-118.
3. Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 1995; 19: S37-434.
4. Correa P. Stomach. In: Franco E, Rohan T, eds. Cancer Precursors: Epidemiology, detection and prevention. New York: Springer, 2002.
5. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979; 3: 191-9.
6. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J. Gastroenterol. Hepatol. 2009; 24: 193-201. DOI: 10.1111/j.1440-1746.2008.05774.x.
7. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am. J. Gastroenterol. 2010; 105: 493-8.
8. Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94. DOI: 10.1055/s-0031-1291491.
9. González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int. J. Cancer 2013 (Sep 1); 133 (5): 1023-32.
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996; 20: 1161-81.
11. Filipe MI, Muñoz N, Matko I et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 1994 (May 1); 57 (3): 324-9.
12. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007; 12: 1-15.
13. González CA, Pardo ML, Liso JM et al. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Int. J. Cancer 2010 (Dec 1); 127 (11): 2654-60.
14. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J. Clin. Pathol. 2004; 57: 177-82.
15. Lin CK, Lai KH, Lo GH et al. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach. Zhonghua Yi Xue Za Zhi (Taipei) 2001; 64: 331-6.
16. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110-3.
17. Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990; 31: 1097-104.
18. Tava F, Luinetti O, Ghigna MR et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Hum. Pathol. 2006; 37: 1489-97.
19. Ramesar KC, Sanders DS, Hopwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J. Clin. Pathol. 1987; 40: 1287-90.
20. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am. J. Gastroenterol. 2000; 95: 1431-8.